There were 1,459 press releases posted in the last 24 hours and 442,753 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Ascendis Pharma A/S Announces Submission of Biologics License Application (BLA) to FDA for TransCon™ hGH in Pediatric Growth Hormone Deficiency

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image